Kv1.3 Therapeutics' Debt Round

Kv1.3 Therapeutics raised a round of funding on January 10, 2018.

Kv1.3 Therapeutics is a biopharmaceutical focused on developing new treatment options for rare autoimmune diseases.…

Articles about Kv1.3 Therapeutics' Debt Round: